文献速递医学教育与科研方法流行病学与生物统计

姑息治疗试验中缺失数据报告与处理质量表明需进一步完善CONSORT声明:一项系统评价

Quality of missing data reporting and handling in palliative care trials demonstrates that further development of the CONSORT statement is required: a systematic review.
PubMed 文献 · J Clin Epidemiol · 2017-05-19

该系统评价纳入2009至2014年108项姑息治疗随机对照试验(15,560例受试者),评估缺失数据报告与处理质量。结果显示缺失数据报告不完整且未按现行指南处理;CONSORT规定的报告条目报告较好,但纳入量表总分的条目(10%)和次要结局(9%)的缺失数据报告较差,缺失数据比例可能被低估。

要点

  • 108项姑息治疗随机对照试验中,缺失数据报告不完整且未按现行指南处理。
  • CONSORT规定的报告条目报告较好:受试者流程69%、未纳入主要结局分析的受试者数94%、缺失原因71%。
  • 纳入量表总分的条目(10%)和次要结局(9%)的缺失数据报告较差,仅16%的试验报告了缺失数据敏感性分析。

核心结论

  • 进一步完善CONSORT缺失数据报告指南可能提高报告质量,原文提供了报告建议。

研究设计与样本

  • 系统评价,检索CENTRAL、MEDLINE和EMBASE(2009-2014年),纳入108项姑息治疗随机对照试验(15,560例受试者)。

主要发现

  • 缺失数据报告不完整且未按现行指南处理;CONSORT规定的报告条目报告较好:受试者流程69%、未纳入主要结局分析的受试者数94%、缺失原因71%。
  • 纳入量表总分的条目(10%)和次要结局(9%)的缺失数据报告较差,所报告的缺失数据比例可能被低估。
  • 54%的受试者缺失原因不明确,仅16%存在缺失数据的试验报告了缺失数据敏感性分析。
  • 随着期刊影响因子升高及期刊认可CONSORT声明,报告多数缺失数据及其他偏倚风险报告条目的比值比增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Assess (i) the quality of reporting and handling of missing data (MD) in palliative care trials, (ii) whether there are differences in the reporting of criteria specified by the Consolidated Standards of Reporting Trials (CONSORT) 2010 statement compared with those not specified, and (iii) the association of the reporting of MD with journal impact factor and CONSORT endorsement status. STUDY DESIGN AND SETTING: Systematic review of palliative care randomized controlled trials. CENTRAL, MEDLINE, and EMBASE (2009-2014) were searched. RESULTS: One hundred and eight trials (15,560 participants) were included. MD was incompletely reported and not handled in accordance with current guidance. Reporting criteria specified by the CONSORT statement were better reported than those not specified (participant flow, 69%; number of participants not included in the primary outcome analysis, 94%; and the reason for MD, 71%). However, MD in items contributing to scale summaries (10%) and secondary outcomes (9%) were poorly reported, so the proportion of MD stated is likely to be an underestimate. The reason for MD provided was unclear for 54% of participants and only 16% of trials with MD reported a MD sensitivity analysis. The odds of reporting most of the MD and other risk of bias reporting criteria were increased as the journal impact factor increased and in journals that endorsed the CONSORT statement. CONCLUSION: Further development of the CONSORT MD reporting guidance is likely to improve the quality of reporting. Reporting recommendations are provided.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Hussain JA, Bland M, Langan D, et al. Quality of missing data reporting and handling in palliative care trials demonstrates that further development of the CONSORT statement is required: a systematic review. J Clin Epidemiol. 2017. PMID: 28532739. doi:10.1016/j.jclinepi.2017.05.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。